List of Excipients in API cyproheptadine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing cyproheptadine
Detailed excipient profiles for cyproheptadine
Excipient focus: ALCOHOL
cyproheptadine drug variants containing ALCOHOL
cyproheptadine drug variants not containing ALCOHOL
Excipient focus: ANHYDROUS CITRIC ACID
cyproheptadine drug variants containing ANHYDROUS CITRIC ACID
cyproheptadine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYLATED HYDROXYANISOLE
cyproheptadine drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | cyproheptadine hydrochloride | 0527-1949 |
| Chartwell RX LLC | cyproheptadine hydrochloride | 62135-949 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
cyproheptadine drug variants containing CELLULOSE, MICROCRYSTALLINE
cyproheptadine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
cyproheptadine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | cyproheptadine | 0121-0788 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C YELLOW NO. 10
cyproheptadine drug variants containing D&C YELLOW NO. 10
cyproheptadine drug variants not containing D&C YELLOW NO. 10
Excipient focus: EDETATE DISODIUM
cyproheptadine drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | cyproheptadine hydrochloride | 27808-099 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing EDETATE DISODIUM
Excipient focus: LACTOSE MONOHYDRATE
cyproheptadine drug variants containing LACTOSE MONOHYDRATE
cyproheptadine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
cyproheptadine drug variants containing MAGNESIUM STEARATE
cyproheptadine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MINT
cyproheptadine drug variants containing MINT
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | cyproheptadine hydrochloride | 27808-099 |
| Patrin Pharma | cyproheptadine hydrochloride | 39328-044 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing MINT
Excipient focus: PEPPERMINT
cyproheptadine drug variants containing PEPPERMINT
cyproheptadine drug variants not containing PEPPERMINT
Excipient focus: PROPYLENE GLYCOL
cyproheptadine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | cyproheptadine hydrochloride | 0527-1949 |
| Chartwell RX LLC | cyproheptadine hydrochloride | 62135-949 |
| QUAGEN PHARMACEUTICALS LLC | cyproheptadine hydrochloride | 70752-101 |
| Bryant Ranch Prepack | cyproheptadine hydrochloride | 72162-2065 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
cyproheptadine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | cyproheptadine hydrochloride | 62135-236 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
cyproheptadine drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | cyproheptadine | 0121-0788 |
| Tris Pharma Inc | cyproheptadine hydrochloride | 27808-099 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CITRATE
cyproheptadine drug variants containing SODIUM CITRATE
cyproheptadine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
cyproheptadine drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
cyproheptadine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
cyproheptadine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
cyproheptadine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBIC ACID
cyproheptadine drug variants containing SORBIC ACID
cyproheptadine drug variants not containing SORBIC ACID
Excipient focus: STARCH, CORN
cyproheptadine drug variants containing STARCH, CORN
cyproheptadine drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
cyproheptadine drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | cyproheptadine hydrochloride | 62135-236 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing STEARIC ACID
Excipient focus: SUCRALOSE
cyproheptadine drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | cyproheptadine hydrochloride | 0527-1949 |
| Chartwell RX LLC | cyproheptadine hydrochloride | 62135-949 |
| >Company | >Ingredient | >NDC |
cyproheptadine drug variants not containing SUCRALOSE
Excipient focus: SUCROSE
cyproheptadine drug variants containing SUCROSE
cyproheptadine drug variants not containing SUCROSE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
cyproheptadine drug variants containing TRISODIUM CITRATE DIHYDRATE
cyproheptadine drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
cyproheptadine drug variants containing WATER
cyproheptadine drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
